Suppr超能文献

肾病综合征:水肿形成及其利尿剂治疗

Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.

作者信息

Gupta Sanjana, Pepper Ruth J, Ashman Neil, Walsh Stephen B

机构信息

UCL Centre for Nephrology, University College London, London, United Kingdom.

Renal Unit, The Royal London Hospital, Bart's Health NHS Trust, London, United Kingdom.

出版信息

Front Physiol. 2019 Jan 15;9:1868. doi: 10.3389/fphys.2018.01868. eCollection 2018.

Abstract

Oedema is a defining element of the nephrotic syndrome. Its' management varies considerably between clinicians, with no national or international clinical guidelines, and hence variable outcomes. Oedema may have serious sequelae such as immobility, skin breakdown and local or systemic infection. Treatment of nephrotic oedema is often of limited efficacy, with frequent side-effects and interactions with other pharmacotherapy. Here, we describe the current paradigms of oedema in nephrosis, including insights into emerging mechanisms such as the role of the abnormal activation of the epithelial sodium channel in the collecting duct. We then discuss the physiological basis for traditional and novel therapies for the treatment of nephrotic oedema. Despite being the cardinal symptom of nephrosis, few clinical studies guide clinicians to the rational use of therapy. This is reflected in the scarcity of publications in this field; it is time to undertake new clinical trials to direct clinical practice.

摘要

水肿是肾病综合征的一个决定性要素。临床医生对其处理方法差异很大,目前尚无国家或国际临床指南,因此治疗结果也各不相同。水肿可能会引发严重的后遗症,如活动受限、皮肤破损以及局部或全身感染。肾病性水肿的治疗效果往往有限,且经常出现副作用,还会与其他药物治疗产生相互作用。在此,我们描述了当前肾病中水肿的范式,包括对一些新出现机制的见解,如集合管上皮钠通道异常激活所起的作用。然后我们讨论了治疗肾病性水肿的传统疗法和新疗法的生理基础。尽管水肿是肾病的主要症状,但很少有临床研究指导临床医生合理使用治疗方法。这反映在该领域的出版物较少;现在是时候开展新的临床试验来指导临床实践了。

相似文献

1
Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.肾病综合征:水肿形成及其利尿剂治疗
Front Physiol. 2019 Jan 15;9:1868. doi: 10.3389/fphys.2018.01868. eCollection 2018.
7
Mechanisms of renal NaCl retention in proteinuric disease.蛋白尿性疾病中肾脏 NaCl 潴留的机制。
Acta Physiol (Oxf). 2013 Mar;207(3):536-45. doi: 10.1111/apha.12047. Epub 2013 Jan 7.

引用本文的文献

3
Membranous nephropathy: pathogenesis and treatments.膜性肾病:发病机制与治疗
MedComm (2020). 2024 Jun 29;5(7):e614. doi: 10.1002/mco2.614. eCollection 2024 Jul.
8
Glomerulonephritis: immunopathogenesis and immunotherapy.肾小球肾炎:免疫发病机制与免疫治疗。
Nat Rev Immunol. 2023 Jul;23(7):453-471. doi: 10.1038/s41577-022-00816-y. Epub 2023 Jan 12.

本文引用的文献

1
Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension.尿纤溶酶(原)作为高血压的一个预后因素
Kidney Int Rep. 2018 Jun 30;3(6):1434-1442. doi: 10.1016/j.ekir.2018.06.007. eCollection 2018 Nov.
10
Trial of Amiloride in Type 2 Diabetes with Proteinuria.氨氯吡咪治疗2型糖尿病合并蛋白尿的试验
Kidney Int Rep. 2017 Sep;2(5):893-904. doi: 10.1016/j.ekir.2017.05.008. Epub 2017 May 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验